| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10039991 | HBV | ENSG00000026751.17 | protein_coding | SLAMF7 | No | No | 57823 | B4DVL7 B4DW98 Q9NQ25 |
| TVIS10033483 | HBV | ENSG00000026751.17 | protein_coding | SLAMF7 | No | No | 57823 | B4DVL7 B4DW98 Q9NQ25 |
| TVIS30001659 | HIV | ENSG00000026751.17 | protein_coding | SLAMF7 | No | No | 57823 | B4DVL7 B4DW98 Q9NQ25 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLAMF7 |
|---|---|
| DrugBank ID | DB06317 |
| Drug Name | Elotuzumab |
| Target ID | BE0003492 |
| UniProt ID | Q9NQ25 |
| Regulation Type | modulator |
| PubMed IDs | 26809244 |
| Citations | Markham A: Elotuzumab: First Global Approval. Drugs. 2016 Mar;76(3):397-403. doi: 10.1007/s40265-016-0540-0. |
| Groups | Approved |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1743010 |
